We compared the potentially immunotherapeutic protection of both types of vaccines in a 38C13 LMP1-expressing mouse B cell tumor model, with the goal to promote survival in a mouse B cell model of EBV-associated lymphoma. This evidence concerns the gene PDLIM7 and lymphoma.